Prof. Rebecca Cox

Rebecca Cox is professor in medical virology and head of the Influenza Centre at the University of Bergen, Norway leading a team of 14 scientists. Rebecca Cox completed her PhD in 1995 at the London Hospital Medical College, University of London, UK before post doc positions at Guys Hospital, UK and the University of Bergen, Norway. She has >25 years of experience of influenza work particularly in development and evaluation of influenza vaccines. She serves as advisor to the WHO SAGE Immunization Working Group on Influenza and the Norwegian epidemic and pandemic committee. She has led the EU funded preclinical and phase I trials of pandemic/universal vaccines.  

Her research focuses on development and evaluation of influenza vaccine with particular focus on human immune responses to infection and vaccination. She is Company Secretary/Board member of the International Society for Influenza and Other Respiratory Viruses and senior editor for the journal Influenza and Other Respiratory Viruses and associate editor of the journals human vaccines and immunotherapeutics and Vaccines and Molecular Therapeutics (specialty section of Frontiers in Immunology and Frontiers in Public Health). She is author of more than 100 peer-reviewed papers and regularly contributes to the public debate on influenza and vaccines through multi-media channels.